Population pharmacokinetics of sildenafil in extremely premature infants

Aims To characterize the population pharmacokinetics (PK) of sildenafil and its active metabolite, N‐desmethyl sildenafil (DMS), in premature infants. Methods We performed a multicentre, open‐label trial to characterize the PK of sildenafil in infants ≤28 weeks gestation and 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of clinical pharmacology 2019-12, Vol.85 (12), p.2824-2837
Hauptverfasser: Gonzalez, Daniel, Laughon, Matthew M., Smith, P. Brian, Ge, Shufan, Ambalavanan, Namasivayam, Atz, Andrew, Sokol, Gregory M., Hornik, Chi D., Stewart, Dan, Mundakel, Gratias, Poindexter, Brenda B., Gaedigk, Roger, Mills, Mary, Cohen‐Wolkowiez, Michael, Martz, Karen, Hornik, Christoph P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims To characterize the population pharmacokinetics (PK) of sildenafil and its active metabolite, N‐desmethyl sildenafil (DMS), in premature infants. Methods We performed a multicentre, open‐label trial to characterize the PK of sildenafil in infants ≤28 weeks gestation and 
ISSN:0306-5251
1365-2125
1365-2125
DOI:10.1111/bcp.14111